Drug intelligence / Profile preview

Cedium

Development stage
Unknown
Lead developer
Qualiphar
Modality
Small Molecules
Administration
Topical
01

Overview

Cedium is a brand of topical antiseptic and disinfectant products developed by the Belgian healthcare company Qualiphar, primarily used for wound care and skin disinfection. The product line includes several formulations, most notably Cedium Chlorhexidine (containing chlorhexidine digluconate) and Cedium Benzalkonium (containing benzalkonium chloride). These agents function as broad-spectrum antimicrobials by disrupting microbial cell membranes. Chlorhexidine, a cationic biguanide, binds to the negatively charged surfaces of bacteria, leading to increased permeability and the leakage of intracellular components. Benzalkonium chloride, a quaternary ammonium compound, similarly acts as a surface-active agent that destabilizes the lipid bilayer of microorganisms. Cedium products are available as aqueous or alcoholic solutions and sprays for the treatment of minor wounds, abrasions, and for preoperative skin preparation.

Brand names
CediumCedium ChlorhexidineCedium BenzalkoniumCedium Med

Beyond the preview

Go deeper on Cedium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cedium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call